|
rs10760130 |
SNP |
PedAM |
snpId=rs10760130; pubmedId=20498205; geneId=3899; geneSymbol=AFF3; diseaseId=umls:C0003873; sourceId=BeFree; sentence=Eight markers (ie, rs1160542 (AFF3), rs1678542 (KIF5A), rs2476601 (PTPN22), rs3087243 (CTLA4), rs4810485 (CD40), rs5029937 (6q23), rs10760130 (TRAF1/C5) and rs7574865 (STAT4)) were significantly associated with RA by meta-analysis.; score=0.129001189; Year=2010; geneSymbol_dbSNP=NA; CHROMOSOME=9; POS=120939712; REF=G; ALT=A |
details
|
|
|
rs10798269 |
SNP |
PedAM |
snpId=rs10798269; pubmedId=19714582; geneId=4204; geneSymbol=MECP2; diseaseId=umls:C0003873; sourceId=BeFree; sentence=A characteristic single-nucleotide polymorphism (SNP) in each of 9 genetic factors, ITGAM (rs1143679), C8orf13-BLK (rs13277113), TYK2 (rs2304256), 1q25.1 (rs10798269), PXK (rs6445975), KIAA1542 (rs4963128), MECP2 (rs17435), BANK1 (rs17266594), and LY9 (rs509749), was studied in 1,635 patients with RA and 1,906 control subjects from Spain.; score=0.120814326; Year=2009; geneSymbol_dbSNP=LOC100506023; CHROMOSOME=1; POS=173340574; REF=A; ALT=G,T |
details
|
|
|
rs10798269 |
SNP |
PedAM |
snpId=rs10798269; pubmedId=19714582; geneId=54899; geneSymbol=PXK; diseaseId=umls:C0003873; sourceId=BeFree; sentence=A characteristic single-nucleotide polymorphism (SNP) in each of 9 genetic factors, ITGAM (rs1143679), C8orf13-BLK (rs13277113), TYK2 (rs2304256), 1q25.1 (rs10798269), PXK (rs6445975), KIAA1542 (rs4963128), MECP2 (rs17435), BANK1 (rs17266594), and LY9 (rs509749), was studied in 1,635 patients with RA and 1,906 control subjects from Spain.; score=0.125005506; Year=2009; geneSymbol_dbSNP=LOC100506023; CHROMOSOME=1; POS=173340574; REF=A; ALT=G,T |
details
|
|
|
rs10798269 |
SNP |
PedAM |
snpId=rs10798269; pubmedId=19714582; geneId=3684; geneSymbol=ITGAM; diseaseId=umls:C0003873; sourceId=BeFree; sentence=A characteristic single-nucleotide polymorphism (SNP) in each of 9 genetic factors, ITGAM (rs1143679), C8orf13-BLK (rs13277113), TYK2 (rs2304256), 1q25.1 (rs10798269), PXK (rs6445975), KIAA1542 (rs4963128), MECP2 (rs17435), BANK1 (rs17266594), and LY9 (rs509749), was studied in 1,635 patients with RA and 1,906 control subjects from Spain.; score=0.000814326; Year=2009; geneSymbol_dbSNP=LOC100506023; CHROMOSOME=1; POS=173340574; REF=A; ALT=G,T |
details
|
|
|
rs10798269 |
SNP |
PedAM |
snpId=rs10798269; pubmedId=19714582; geneId=55024; geneSymbol=BANK1; diseaseId=umls:C0003873; sourceId=BeFree; sentence=A characteristic single-nucleotide polymorphism (SNP) in each of 9 genetic factors, ITGAM (rs1143679), C8orf13-BLK (rs13277113), TYK2 (rs2304256), 1q25.1 (rs10798269), PXK (rs6445975), KIAA1542 (rs4963128), MECP2 (rs17435), BANK1 (rs17266594), and LY9 (rs509749), was studied in 1,635 patients with RA and 1,906 control subjects from Spain.; score=0.003181358; Year=2009; geneSymbol_dbSNP=LOC100506023; CHROMOSOME=1; POS=173340574; REF=A; ALT=G,T |
details
|
|
|
rs10818488 |
SNP |
PedAM |
snpId=rs10818488; pubmedId=19445664; geneId=7185; geneSymbol=TRAF1; diseaseId=umls:C0003873; sourceId=BeFree; sentence=No statistically significant association of TRAF1/C5 SNPs rs3761847 and rs10818488 with RA was detected.; score=0.311201237; Year=2009; geneSymbol_dbSNP=NA; CHROMOSOME=9; POS=120942809; REF=A; ALT=G |
details
|
|
|
rs10818488 |
SNP |
PedAM |
snpId=rs10818488; pubmedId=23321589; geneId=7124; geneSymbol=TNF; diseaseId=umls:C0003873; sourceId=BeFree; sentence=To determine whether the tumor necrosis factor (TNF)-receptor associated factor 1/complement component 5 (TRAF1/C5) polymorphism (rs10818488) confers susceptibility to rheumatoid arthritis (RA) and systemic lupus erythematous (SLE), a meta-analysis was performed.; score=0.425384406; Year=2013; geneSymbol_dbSNP=NA; CHROMOSOME=9; POS=120942809; REF=A; ALT=G |
details
|
|
|
rs10818488 |
SNP |
PedAM |
snpId=rs10818488; pubmedId=23321589; geneId=727; geneSymbol=C5; diseaseId=umls:C0003873; sourceId=BeFree; sentence=To determine whether the tumor necrosis factor (TNF)-receptor associated factor 1/complement component 5 (TRAF1/C5) polymorphism (rs10818488) confers susceptibility to rheumatoid arthritis (RA) and systemic lupus erythematous (SLE), a meta-analysis was performed.; score=0.039672916; Year=2013; geneSymbol_dbSNP=NA; CHROMOSOME=9; POS=120942809; REF=A; ALT=G |
details
|
|
|
rs10818488 |
SNP |
PedAM |
snpId=rs10818488; pubmedId=24338224; geneId=7185; geneSymbol=TRAF1; diseaseId=umls:C0003873; sourceId=BeFree; sentence=Lack of association between single nucleotide polymorphism rs10818488 in TRAF1/C5 region and rheumatoid arthritis in iranian population.; score=0.311201237; Year=2013; geneSymbol_dbSNP=NA; CHROMOSOME=9; POS=120942809; REF=A; ALT=G |
details
|
|
|
rs10818488 |
SNP |
PedAM |
snpId=rs10818488; pubmedId=23321589; geneId=7185; geneSymbol=TRAF1; diseaseId=umls:C0003873; sourceId=BeFree; sentence=Association study of TRAF1/C5 polymorphism (rs10818488) with susceptibility to rheumatoid arthritis and systemic lupus erythematosus: a meta-analysis.; score=0.311201237; Year=2013; geneSymbol_dbSNP=NA; CHROMOSOME=9; POS=120942809; REF=A; ALT=G |
details
|
|
|
rs10818488 |
SNP |
PedAM |
snpId=rs10818488; pubmedId=24234752; geneId=5657; geneSymbol=PRTN3; diseaseId=umls:C0003873; sourceId=BeFree; sentence=Stratified analyses indicated that the TRAF1/C5 rs10818488 A allele was significantly associated with RA in Caucasians (OR = 1.29, 95 %CI = 1.14¨C1.47, P heterogeneity = 0.026), Asians (OR = 0.92, 95 %CI = 0.86¨C0.99, P heterogeneity = 0.378) and Africans (OR = 1.56, 95 %CI = 1.23¨C1.98, P heterogeneity = 0.876), also significantly in positive ACPA and positive RF patients versus controls (ORs were 1.20 and 1.25, 95 %CIs were 1.08¨C1.33 and 1.14¨C1.37, P values for heterogeneity were 0.215 and 0.133, respectively).; score=0.00842463; Year=2013; geneSymbol_dbSNP=NA; CHROMOSOME=9; POS=120942809; REF=A; ALT=G |
details
|
|
|
rs10821944 |
SNP |
PedAM |
snpId=rs10821944; pubmedId=23577190; geneId=1437; geneSymbol=CSF2; diseaseId=umls:C0003873; sourceId=BeFree; sentence=Genetic factors regarded as putative risk factors were RA-susceptible polymorphisms identified by the Japanese GWAS meta-analysis, including HLA-DRB1 (shared epitope, SE), rs2240340 (PADI4), rs2230926 (TNFAIP3), rs3093024 (CCR6), rs11900673 (B3GNT2), rs2867461 (ANXA3), rs657075 (CSF2), rs12529514 (CD83), rs2233434 (NFKBIE), rs10821944 (ARID5B), rs3781913 (PDE2A-ARAP1), rs2841277 (PLD4) and rs2847297 (PTPN2).; score=0.129424521; Year=2013; geneSymbol_dbSNP=ARID5B; CHROMOSOME=10; POS=62025330; REF=G; ALT=T |
details
|
|
|
rs10821944 |
SNP |
PedAM |
snpId=rs10821944; pubmedId=22446963; geneId=84159; geneSymbol=ARID5B; diseaseId=umls:C0003873; sourceId=GWASCAT; sentence=Our study identified nine loci newly associated with rheumatoid arthritis at a threshold of P < 5.0 ¡Á 10(-8), including B3GNT2, ANXA3, CSF2, CD83, NFKBIE, ARID5B, PDE2A-ARAP1, PLD4 and PTPN2.; score=0.242909916; Year=2012; geneSymbol_dbSNP=ARID5B; CHROMOSOME=10; POS=62025330; REF=G; ALT=T |
details
|
|
|
rs10821944 |
SNP |
PedAM |
snpId=rs10821944; pubmedId=23577190; geneId=9034; geneSymbol=CCRL2; diseaseId=umls:C0003873; sourceId=BeFree; sentence=Genetic factors regarded as putative risk factors were RA-susceptible polymorphisms identified by the Japanese GWAS meta-analysis, including HLA-DRB1 (shared epitope, SE), rs2240340 (PADI4), rs2230926 (TNFAIP3), rs3093024 (CCR6), rs11900673 (B3GNT2), rs2867461 (ANXA3), rs657075 (CSF2), rs12529514 (CD83), rs2233434 (NFKBIE), rs10821944 (ARID5B), rs3781913 (PDE2A-ARAP1), rs2841277 (PLD4) and rs2847297 (PTPN2).; score=0.005710211; Year=2013; geneSymbol_dbSNP=ARID5B; CHROMOSOME=10; POS=62025330; REF=G; ALT=T |
details
|
|
|
rs10821944 |
SNP |
PedAM |
snpId=rs10821944; pubmedId=23577190; geneId=5771; geneSymbol=PTPN2; diseaseId=umls:C0003873; sourceId=BeFree; sentence=Genetic factors regarded as putative risk factors were RA-susceptible polymorphisms identified by the Japanese GWAS meta-analysis, including HLA-DRB1 (shared epitope, SE), rs2240340 (PADI4), rs2230926 (TNFAIP3), rs3093024 (CCR6), rs11900673 (B3GNT2), rs2867461 (ANXA3), rs657075 (CSF2), rs12529514 (CD83), rs2233434 (NFKBIE), rs10821944 (ARID5B), rs3781913 (PDE2A-ARAP1), rs2841277 (PLD4) and rs2847297 (PTPN2).; score=0.248458305; Year=2013; geneSymbol_dbSNP=ARID5B; CHROMOSOME=10; POS=62025330; REF=G; ALT=T |
details
|
|
|
rs10821944 |
SNP |
PedAM |
snpId=rs10821944; pubmedId=23577190; geneId=10678; geneSymbol=B3GNT2; diseaseId=umls:C0003873; sourceId=BeFree; sentence=Genetic factors regarded as putative risk factors were RA-susceptible polymorphisms identified by the Japanese GWAS meta-analysis, including HLA-DRB1 (shared epitope, SE), rs2240340 (PADI4), rs2230926 (TNFAIP3), rs3093024 (CCR6), rs11900673 (B3GNT2), rs2867461 (ANXA3), rs657075 (CSF2), rs12529514 (CD83), rs2233434 (NFKBIE), rs10821944 (ARID5B), rs3781913 (PDE2A-ARAP1), rs2841277 (PLD4) and rs2847297 (PTPN2).; score=0.123181358; Year=2013; geneSymbol_dbSNP=ARID5B; CHROMOSOME=10; POS=62025330; REF=G; ALT=T |
details
|
|
|
rs10821944 |
SNP |
PedAM |
snpId=rs10821944; pubmedId=22446963; geneId=84159; geneSymbol=ARID5B; diseaseId=umls:C0003873; sourceId=GAD; sentence=[Our study identified nine loci newly associated with rheumatoid arthritis at a threshold of P < 5.0 A 10(-8), including B3GNT2, ANXA3, CSF2, CD83, NFKBIE, ARID5B, PDE2A-ARAP1, PLD4 and PTPN2.]; score=0.242909916; Year=2012; geneSymbol_dbSNP=ARID5B; CHROMOSOME=10; POS=62025330; REF=G; ALT=T |
details
|
|
|
rs10821944 |
SNP |
PedAM |
snpId=rs10821944; pubmedId=23577190; geneId=116985; geneSymbol=ARAP1; diseaseId=umls:C0003873; sourceId=BeFree; sentence=Genetic factors regarded as putative risk factors were RA-susceptible polymorphisms identified by the Japanese GWAS meta-analysis, including HLA-DRB1 (shared epitope, SE), rs2240340 (PADI4), rs2230926 (TNFAIP3), rs3093024 (CCR6), rs11900673 (B3GNT2), rs2867461 (ANXA3), rs657075 (CSF2), rs12529514 (CD83), rs2233434 (NFKBIE), rs10821944 (ARID5B), rs3781913 (PDE2A-ARAP1), rs2841277 (PLD4) and rs2847297 (PTPN2).; score=0.000271442; Year=2013; geneSymbol_dbSNP=ARID5B; CHROMOSOME=10; POS=62025330; REF=G; ALT=T |
details
|
|
|
rs10821944 |
SNP |
PedAM |
snpId=rs10821944; pubmedId=23577190; geneId=7128; geneSymbol=TNFAIP3; diseaseId=umls:C0003873; sourceId=BeFree; sentence=Genetic factors regarded as putative risk factors were RA-susceptible polymorphisms identified by the Japanese GWAS meta-analysis, including HLA-DRB1 (shared epitope, SE), rs2240340 (PADI4), rs2230926 (TNFAIP3), rs3093024 (CCR6), rs11900673 (B3GNT2), rs2867461 (ANXA3), rs657075 (CSF2), rs12529514 (CD83), rs2233434 (NFKBIE), rs10821944 (ARID5B), rs3781913 (PDE2A-ARAP1), rs2841277 (PLD4) and rs2847297 (PTPN2).; score=0.167568474; Year=2013; geneSymbol_dbSNP=ARID5B; CHROMOSOME=10; POS=62025330; REF=G; ALT=T |
details
|
|
|
rs10821944 |
SNP |
PedAM |
snpId=rs10821944; pubmedId=23577190; geneId=306; geneSymbol=ANXA3; diseaseId=umls:C0003873; sourceId=BeFree; sentence=Genetic factors regarded as putative risk factors were RA-susceptible polymorphisms identified by the Japanese GWAS meta-analysis, including HLA-DRB1 (shared epitope, SE), rs2240340 (PADI4), rs2230926 (TNFAIP3), rs3093024 (CCR6), rs11900673 (B3GNT2), rs2867461 (ANXA3), rs657075 (CSF2), rs12529514 (CD83), rs2233434 (NFKBIE), rs10821944 (ARID5B), rs3781913 (PDE2A-ARAP1), rs2841277 (PLD4) and rs2847297 (PTPN2).; score=0.242638474; Year=2013; geneSymbol_dbSNP=ARID5B; CHROMOSOME=10; POS=62025330; REF=G; ALT=T |
details
|
|
